Our thorough understanding of your therapeutic landscape allows us to find new assets in development, tailored to your specified criteria and indications of interest. The structured approach will start with mapping the relevant TA universe, including a future perspective of the treatment landscape, highlighting the medical and commercial needs. We will identify and benchmark current and future molecules and their market potential. The final step will be the introduction to target companies to initiate partnering discussions.